Dr Reddy's Laboratories consolidated net profit declines 19.40% in the March 2018 quarter

Capital Market 

Sales decline 0.54% to Rs 3534.90 crore

Net profit of declined 19.40% to Rs 272.10 crore in the quarter ended March 2018 as against Rs 337.60 crore during the previous quarter ended March 2017. Sales declined 0.54% to Rs 3534.90 crore in the quarter ended March 2018 as against Rs 3554.20 crore during the previous quarter ended March 2017.

For the full year,net profit declined 26.72% to Rs 946.80 crore in the year ended March 2018 as against Rs 1292.10 crore during the previous year ended March 2017. Sales rose 0.87% to Rs 14202.80 crore in the year ended March 2018 as against Rs 14080.90 crore during the previous year ended March 2017. ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales3534.903554.20 -1 14202.8014080.90 1 OPM %15.9416.61 -16.5517.56 - PBDT590.70591.40 0 2427.602580.30 -6 PBT314.40337.10 -7 1350.401553.70 -13 NP272.10337.60 -19 946.801292.10 -27

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, May 22 2018. 15:55 IST